Growth Metrics

CorMedix (CRMD) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.

  • CorMedix's Income towards Parent Company rose 400227.68% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6252.03% up from last year.
  • Latest data reveals that CorMedix reported Income towards Parent Company of $108.6 million as of Q3 2025, which was up 400227.68% from $19.8 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Income towards Parent Company registered a high of $108.6 million during Q3 2025, and its lowest value of -$14.5 million during Q1 2024.
  • Its 5-year average for Income towards Parent Company is $2.3 million, with a median of -$7.4 million in 2021.
  • Per our database at Business Quant, CorMedix's Income towards Parent Company tumbled by 6414.73% in 2022 and then skyrocketed by 400227.68% in 2025.
  • Quarter analysis of 5 years shows CorMedix's Income towards Parent Company stood at -$7.8 million in 2021, then dropped by 5.36% to -$8.2 million in 2022, then decreased by 18.7% to -$9.7 million in 2023, then surged by 238.18% to $13.5 million in 2024, then skyrocketed by 706.3% to $108.6 million in 2025.
  • Its Income towards Parent Company was $108.6 million in Q3 2025, compared to $19.8 million in Q2 2025 and $20.6 million in Q1 2025.